Arrowhead Pharmaceuticals, Inc.
← Back to ARWR Overview

Arrowhead Pharmaceuticals, Inc. (ARWR)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

75.44

Financial Fundamentals

ARWR • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
1998-03-31-9.75
1998-06-30—
1998-09-30-5.69
1998-12-31-6.50
1999-03-31-4.88
1999-06-300.14
1999-09-30-2.92
1999-12-31-1.38
2000-03-31-4.68
2000-06-30-3.90
2000-09-303.67
2000-12-31-1.55
2001-03-31-1.00
2001-06-30-1.62
2001-09-30-0.65
2001-12-31-0.38
2002-03-31-4.68
2002-06-30-0.31
2002-09-30-0.07
2002-12-31-0.15
2003-03-31-0.09
2003-06-30-0.38
2003-09-300.11
2003-12-31-8.92
2004-03-31-43.48
2004-06-30-37.25
2004-09-30-12.69
2004-12-31-9.52
2005-03-3122.36
2005-06-30-4.41
2005-09-30-7.76
2005-12-31-9.48
2006-03-31-7.92
2006-06-30-10.44
2006-09-30-4.83
2006-12-31-10.10
2007-03-31-6.20
2007-06-30-3.66
2007-09-30-6.38
2007-12-31-6.97
2008-03-31-4.81
2008-06-30-3.23
2008-09-30-1.29
2008-12-31-1.23
2009-03-31-1.14
2009-06-30-1.89
2009-09-30-2.82
2009-12-31-5.03
2010-03-31-9.67
2010-06-30-47.86
2010-09-30-9.33
2010-12-31-11.17
2011-03-314.63
2011-06-30-5.03
2011-09-30-3.55
2011-12-31-4.27
2012-03-31-3.19
2012-06-30-1.35
2012-09-30-1.71
2012-12-31-1.64
2013-03-31-1.30
2013-06-30-2.18
2013-09-30-3.92
2013-12-31-9.63
2014-03-31-13.05
2014-06-30-15.98
2014-09-30-8.90
2014-12-31-4.47
2015-03-31-3.29
2015-06-30-6.62
2015-09-30-3.47
2015-12-31-4.75
2016-03-31-3.44
2016-06-30-4.11
2016-09-30-5.91
2016-12-31-2.28
2017-03-31-5.71
2017-06-30-5.49
2017-09-30-7.54
2017-12-31-5.11
2018-03-31-10.01
2018-06-30-18.89
2018-09-30-40.65
2018-12-3123.50
2019-03-3118.03
2019-06-3030.92
2019-09-3057.39
2019-12-31-575.98
2020-03-31-35.96
2020-06-30-80.79
2020-09-30-22.75
2020-12-31-95.08
2021-03-31-63.76
2021-06-30-71.40
2021-09-30-25.68
2021-12-31-27.56
2022-03-3127.35
2022-06-30-12.92
2022-09-30-10.22
2022-12-31-26.02
2023-03-3113.93
2023-06-30-9.27
2023-09-30-6.57
2023-12-31-6.18
2024-03-31-6.95
2024-06-30-4.74
2024-09-30-3.46
2024-12-31-3.39
2025-03-311.15
2025-06-30-3.13
2025-09-30-49.27
2025-12-3175.44

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.